In conclusion, we have comprehensively demonstrated that the TCF7L2-rs7903146 polymorphism interacts with obesity status in determining T2D risk, emphasizing the heterogeneity of genetic variants’ T2D risk prediction. This evidence concerns the gene TCF7L2 and obesity disorder.